A citation-based method for searching scientific literature

Barry M Massie, Peter E Carson, John J McMurray, Michel Komajda, Robert McKelvie, Michael R Zile, Susan Anderson, Mark Donovan, Erik Iverson, Christoph Staiger, Agata Ptaszynska. N Engl J Med 2008
Times Cited: 1222



Theresa A McDonagh, Marco Metra, Marianna Adamo, Roy S Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel, John G F Cleland, Andrew J S Coats, Maria G Crespo-Leiro, Dimitrios Farmakis, Martine Gilard, Stephane Heymans, Arno W Hoes, Tiny Jaarsma, Ewa A Jankowska, Mitja Lainscak, Carolyn S P Lam, Alexander R Lyon, John J V McMurray, Alexandre Mebazaa, Richard Mindham, Claudio Muneretto, Massimo Francesco Piepoli, Susanna Price, Giuseppe M C Rosano, Frank Ruschitzka, Anne Kathrine Skibelund. Eur Heart J 2021
Times Cited: 656




List of shared articles



Times cited

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial.
Lars H Lund, Gianluigi Savarese, Ashwin Venkateshvaran, Lina Benson, Anna Lundberg, Erwan Donal, Jean-Claude Daubert, Emmanuel Oger, Cecilia Linde, Camilla Hage. ESC Heart Fail 2022
1


Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin.
Alberto Aimo, Michele Senni, Andrea Barison, Giorgia Panichella, Claudio Passino, Antoni Bayes-Genis, Michele Emdin. Heart Fail Rev 2022
0

Current and future therapeutic perspective in chronic heart failure.
Annamaria Mascolo, Gabriella di Mauro, Donato Cappetta, Antonella De Angelis, Daniele Torella, Konrad Urbanek, Liberato Berrino, Giovanni Francesco Nicoletti, Annalisa Capuano, Francesco Rossi. Pharmacol Res 2022
0



SGLT2 Inhibitors in Older Adults with Heart Failure with Preserved Ejection Fraction.
Julie Hias, Laura Hellemans, Karolien Walgraeve, Jos Tournoy, Lorenz Van der Linden. Drugs Aging 2022
0

Signaling cascades in the failing heart and emerging therapeutic strategies.
Xin He, Tailai Du, Tianxin Long, Xinxue Liao, Yugang Dong, Zhan-Peng Huang. Signal Transduct Target Ther 2022
0

Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology.
Pasquale Perrone-Filardi, Stefania Paolillo, Piergiuseppe Agostoni, Christian Basile, Cristina Basso, Francesco Barillà, Michele Correale, Antonio Curcio, Massimo Mancone, Marco Merlo,[...]. Eur J Intern Med 2022
0


Effect of Sodium-Glucose Cotransporter 2 Inhibitors for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Hufang Zhou, Wenhua Peng, Fuyao Li, Yuelin Wang, Baofu Wang, Yukun Ding, Qian Lin, Ying Zhao, Guozhong Pan, Xian Wang. Front Cardiovasc Med 2022
0

[SEMERGEN positioning on approaching chronic heart failure in primary care].
M J Castillo Moraga, M Turégano-Yedro, V Pallarés-Carratalá, M C Seoane-Vicente, A Serrano Cumplido, A Ruiz-García, E Martin-Rioobó, C Escobar-Cervantes, J Polo-García, V Barrios. Semergen 2022
0

Hospitalisations in HFpEF: More than just a matter of the heart.
Giovanni Civieri, Francesco Tona. Eur J Clin Invest 2022
0

Heart failure with preserved ejection fraction: Squaring the circle between comorbidities and cardiovascular abnormalities.
Alberto Maria Marra, Leonardo Bencivenga, Roberta D'Assante, Giuseppe Rengo, Antonio Cittadini. Eur J Intern Med 2022
0

Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy.
Jakub Benko, Matej Samoš, Tomáš Bolek, Dana Prídavková, Jakub Jurica, Martin Jozef Péč, Peter Galajda, Marián Mokáň. J Diabetes Res 2022
0